AI assistant
Sending…
Praxis Precision Medicines, Inc. — Director's Dealing 2021
Apr 30, 2021
32153_dirs_2021-04-30_7ffd2b25-5bba-42d9-809b-c4c4e4eddbbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2021-04-28
Reporting Person: Cudkowicz Merit Ester (Director)
More from Praxis Precision Medicines, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 14
Annual Report
2026
Feb 19
Earnings Release
2026
Feb 19
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12